Fingerprint
Dive into the research topics of 'Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically